Last week, readers were most interested in a story about Mursla's liver cancer test for detecting microRNA and protein targets within extracellular vesicles.

NEW YORK – Eight German associations are calling for changes to be made to the European In Vitro Diagnostics Regulation (IVDR ...

NEW YORK – Diagnostic companies saw their stock prices continue to decline in April, falling 4 percent after a 5 percent decline in March, and dipping even deeper than the broader market. The Top 30 ...

NEW YORK – Hologic reported after the close of the market on Thursday that its fiscal second quarter diagnostics revenues rose 1 percent year over year on growth in the company's molecular diagnostics ...

The proceeds will be used to launch a new diagnostic instrument, a breast cancer monitoring assay, and proprietary multiplex immunofluorescence reagent kits.

The former True Health Diagnostics executives were accused of participating in a scheme that paid Texas physicians for blood test referrals.

The company said that its test could overcome sensitivity issues with ultrasound and serum alpha-fetoprotein assays that are used to monitor at-risk patients.

Last week, readers were most interested in a story about Akoya's collaboration to identify markers predictive of response to checkpoint inhibitor therapy.

In one case, a firm is alleged to have improperly billed the COVID-19 Uninsured Program while in the other, a firm paid and received kickbacks for unnecessary genetic testing.